The first case of int1h-related inversion in Japanese haemophilia A patients.
The first case of int1h-related inversion in Japanese haemophilia A patients.
复制标题
日本A型血友病患者中首例与int1h相关的倒位。
作者：
Yada K;Nogami K;Kawamura T;Minami H;Shima M
2009; 65：989-98. [2]刘晓波，王晓波，王晓波.药代动力学在血友病患者凝血因子治疗中的应用。血友病2005; 11：571-82。3柯林斯PW，Bjorkman S，Fischer K等，在重度血友病A的预防性治疗中维持目标血浆水平的因子VIII要求：药代动力学和治疗方案差异的影响。血栓血液学杂志2010; 8：269-75。[4]张晓刚，张晓刚，张晓刚. A型血友病患者体重过轻或超重对因子VIII剂量的影响。Haematologica 2013; 98：1481-6. 10张文，张文，等.凝血因子VIII的生物学特性.中华生化杂志，2000，24（1）：117 - 118
2009; 65: 989–98. 2 Shapiro AD, Korth-Bradley J, Poon MC. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia. Haemophilia 2005; 11: 571–82. 3 Collins PW, Bjorkman S, Fischer K et al. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost 2010; 8:269–75. 4 Henrard S, Speybroeck N, Hermans C. Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients. Haematologica 2013; 98: 1481–6. 5 Vlot AJ, Mauser-Bunschoten EP, Zarkova AG et al. The half-life of infused factor VIII